{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:57:48Z","timestamp":1715986668018},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ijrobp.2009.04.066","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T08:14:02Z","timestamp":1253607242000},"page":"430-437","source":"Crossref","is-referenced-by-count":15,"title":["A Retrospective, Multicenter Study of the Tolerance of Induction Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Radiotherapy With Concomitant Cetuximab in 46 Cases of Squamous Cell Carcinoma of the Head and Neck"],"prefix":"10.1016","volume":"77","author":[{"given":"Guillaume","family":"Buiret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Favrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Ecochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"Fayette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Tartas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Ramade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"C\u00e9ruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.04.066_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archotol.1987.01860020085018","article-title":"Induction chemotherapy in advanced head and neck cancer: A Radiation Therapy Oncology Group study","volume":"113","author":"Jacobs","year":"1987","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/1097-0142(19840901)54:5<811::AID-CNCR2820540508>3.0.CO;2-E","article-title":"Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck","volume":"54","author":"Ensley","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.ijrobp.2009.04.066_bib4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.ijrobp.2007.04.088","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update","volume":"69","author":"Pignon","year":"2007","journal-title":"Int J Radiat Oncol Biophys"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib5","first-page":"14","volume":"22","author":"Vermorken","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib6","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1200\/JCO.2004.00.1990","article-title":"Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer","volume":"23","author":"Hitt","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib7","first-page":"18s","article-title":"Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01","volume":"24","author":"Calais","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib10","first-page":"18","volume":"24","author":"Hitt","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CCO.0b013e3280f00fe7","article-title":"The role of taxanes and targeted therapies in locally advanced head and neck cancer","volume":"19","author":"Specenier","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1146\/annurev.biochem.68.1.965","article-title":"AKT\/PKB and other D3 phosphoinositide-regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation","volume":"68","author":"Chan","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib13","first-page":"1523","volume":"151","author":"Petit","year":"1997","journal-title":"Am\u00a0J\u00a0Pathol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijc.2910530206","article-title":"Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro","volume":"53","author":"Engebraaten","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Rubin Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib16","first-page":"701","article-title":"In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody","volume":"6","author":"Milas","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(00)01488-7","article-title":"Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation","volume":"49","author":"Harari","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib18","first-page":"2166","article-title":"Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis","volume":"6","author":"Huang","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib19","first-page":"602","article-title":"Cell cycle regulation in irradiated and nonirradiated cells","volume":"24","author":"Iliakis","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib21","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","article-title":"Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic\/recurrent head and neck cancer: An Eastern Cooperative Oncology Group study","volume":"23","author":"Burtness","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib22","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2005.04.3547","article-title":"Phase I\/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"24","author":"Bourhis","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2009.04.066_bib23","first-page":"14","article-title":"Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and\/or metastatic squamous cell carcinoma of the head and neck (SCCHN)","volume":"22","author":"Humblet","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib24","first-page":"16s","article-title":"Cetuximab (Erbitux\u00ae) in recurrent\/metastatic (R&M) squamous cell carcinoma of the head and neck (SCCHN) refractory to first\u2013line platinum-based therapies","volume":"23","author":"Vermorken","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib25","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1200\/JCO.2005.07.119","volume":"23","author":"Baselga","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib26","first-page":"14s","article-title":"Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent\/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study","volume":"22","author":"Trigo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib27","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1200\/JCO.2005.07.120","article-title":"Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib28","first-page":"18","article-title":"Induction chemotherapy (CT) with weekly paclitaxel, carboplatin, and cetuximab for squamous cell carcinoma of the head and neck (HN)","volume":"24","author":"Kies","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2004.00.1792","article-title":"Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib31","series-title":"TMN Atlas: Guide illustre de la classification TMN\/pTMN des tumeurs malignes","author":"Wittekind","year":"2006"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib32","series-title":"Mixed effects models in S and S-plus. Statistics and computing series","author":"Pinheiro","year":"2000"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archotol.130.7.861","article-title":"Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: Efficacy, toxic effects, and limitations","volume":"130","author":"Hanna","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib34","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib35","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5","article-title":"A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results","volume":"19","author":"Adelstein","year":"1997","journal-title":"Head Neck"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.04.066_bib37","first-page":"18","article-title":"Pre-treatment and treatment related risk factors for severe late toxicity after chemo-RT for head and neck cancer: An RTOG analysis","volume":"24","author":"Machtay","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.066_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0360-3016(03)01370-1","article-title":"Radiotherapy with concomitant weekly docetaxel for Stages III\/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial","volume":"58","author":"Calais","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T21:22:27Z","timestamp":1544995347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609006646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0360301609006646"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.066","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}